HYPR logo

HYPRHyperfine Inc - Ordinary Shares - Class A

$1.42
$0.02
(1.43%)
Today
Closed $1.42
$0.03
(2.11%)
After Hours
Updated: 07:20 PM EDT
EarningsAug 13
Mkt Cap$138.98M
Vol310,780.00
News
all
press releases
Hyperfine to Join Russell 2000 and Russell 3000 Indexes
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brainthe Swoop system today announced that Hyperfine is expected to join the broad-market Russell 3000 Index and the...
Business Wire
News Placeholder
More News
News Placeholder
Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brainthe Swoop systemtoday announced the presentation of results of the PRIME (Portable Rapid Imaging for Medical...
Business Wire
News Placeholder
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Beats Revenue Estimates
Hyperfine (HYPR) delivered earnings and revenue surprises of 0.00% and +14.12%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Hyperfine Q1 2026 Earnings Call Transcript
read more...
Benzinga
News Placeholder
Hyperfine, Inc. Reports First Quarter 2026 Financial Results
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable magnetic resonance (MR) brain imaging...
Business Wire
News Placeholder
CVRx (CVRX) Reports Q1 Loss, Beats Revenue Estimates
CVRx (CVRX) delivered earnings and revenue surprises of +1.32% and +3.69%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Treace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue Estimates
Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of +9.68% and +2.75%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
News Placeholder
Hyperfine (HYPR) to Release Quarterly Earnings on Tuesday
Hyperfine (NASDAQ:HYPR) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 12. (View Earnings Report at...
MarketBeat
News Placeholder
Short Interest in Hyperfine, Inc. (NASDAQ:HYPR) Drops By 15.3%
Hyperfine, Inc. (NASDAQ:HYPR - Get Free Report) was the target of a large drop in short interest during the month of April. As of April 15th, there was short interest totaling 1,145,426 shares, a...
MarketBeat
News Placeholder
iRadimed (IRMD) Beats Q1 Earnings and Revenue Estimates
iRadimed (IRMD) delivered earnings and revenue surprises of +8.89% and +1.61%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
<
1
2
...
>

Advertisement|Remove ads.